inflammation in the participants, we first analyzed the expression of the inflammation biomarker in prostate cancer cells, used as our baseline data. The pro-inflammatory markers and obesity related genes
Purpose: To assess the diagnostic performance of multiparametric MRI (mpMRI), in the detection of prostate cancer in two different coil setting: endorectal coil (ERC) versus phased array coil alone ... coil imaging of…
acute promyelocytic leukemia (ΑΡL), as well as in metastatic breast cancer, hepatocarcinomas and prostate cancer. Transgenic mice engineered to express cyclin Α1 in myeloid precursor cells develop ΑΜL with ... activated…
Objective: To elucidate the inhibition mechanism of metformin on prostate cancer growth, we studied the effect of metformin in a mouse model. Methods: Six-week old male BALB/c nude ... decreased than control group and…
death in developed countries and it is estimated to become the same worldwide, with prostate cancer being the fourth most common type in the world population. The study of nanovesicles ... action of tumor cell…
Objective: Zoledronic acid (ZA) is highly effective in the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases. It is one of bone modifying agents (BMAs) that ... drugs. However…
progression of BRCA1/2-mutated ovarian cancers in phase-II clinical trials. Metastatic prostate cancer (PCa) is now the second leading cause of cancer deaths among males in the Western
PRLT) with 177Lu-DOTAGA PSMA ligands was performed in 56 progressive, metastasized, castrate-resistant prostate cancer (mCRPC) patients (Baum et al. 2016). Ga-68 PSMA PET/CT was used ... novo) Lu-177 PSMA radioligand…
Patients with lymph node metastases of prostate cancer (LNM) appear to respond better to 177Lu-prostate specific membrane antigen (PSMA)-617 radioligand therapy (RLT) than patients with end-stage prostate…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.